Latest Cancer News

FDA Approves Iobenguane I 131 (Azedra) for Rare Neuroendocrine Tumors (08-2-2018)
The US Food and Drug Administration (FDA) today approved Azedra (iobenguane I 131) for the treatment of pheochromocytoma or paraganglioma, which are rare neuroendocrine tumors of the adrenal gland and... Continue Reading

Tibsovo Approved for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and an IGH1 Mutation (07-23-2018)
Tibsovo® (ivosidenib) has been granted approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) with a... Continue Reading

FDA Approves Kisqali as Initial Endocrine Therapy for Advanced Breast Cancer (07-23-2018)
The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor... Continue Reading

More Cancer News

Locations

VIRGINIA BEACH OFFICE
1200 First Colonial Road
Suite 204
Virginia Beach, VA 23454
Phone (757)363-8212
Fax (757)363-2246
View Map

CHESAPEAKE OFFICE
Chesapeake Medical Center
110 Wimbledon Square
Suite E
Chesapeake, VA 23320
Phone (757)436-2995
Fax (757)436-2912
View Map

SUFFOLK OFFICE
Cancer Specialists of Tidewater
5839 Harbour View Blvd.,
Suite 100
Suffolk, VA 23435
Phone (757)397-4200
Fax (757)397-3872
View Map